Suppr超能文献

中耳上皮细胞在中耳炎中的免疫调节反应。

Immunomodulatory Response of the Middle Ear Epithelial Cells in Otitis Media.

机构信息

Department of Otorhinolaryngology, Head and Neck Surgery, University Medical Center Schleswig-Holstein, Lübeck, Germany.

Department of Surgery/Otolaryngology, University of California, San Diego, CA, USA.

出版信息

Otol Neurotol. 2024 Mar 1;45(3):e248-e255. doi: 10.1097/MAO.0000000000004096. Epub 2024 Jan 17.

Abstract

HYPOTHESIS

The middle ear (ME) epithelium transforms because of changed immunomodulation during infection.

INTRODUCTION

The epithelial cells of the tympanic cavity represent the first line of defense in the context of otitis media. They can convert from a typical mucosal site into a respiratory epithelium and vice versa. Our goal is to depict the specific immune response of epithelial cells after infection at the molecular level.

METHODS

The investigations were carried out on healthy and inflamed ME tissue, removed during surgical interventions in mouse and human models, and in a human in-vitro cell model in human ME epithelial cell line. We determined the epithelial localization of the protein expression of Toll- and NOD-like immune receptors and their associated signaling molecules using immunohistochemistry. In addition, we examined growth behavior and gene expression due to direct stimulation and inhibition.

RESULTS

We found clinically and immunobiologically confirmed transformation of the inflamed ME epithelium depending on their origin, as well as differences in the distribution of Toll-like receptors and nucleotide-binding oligomerization domain-like receptors in the epithelial cell lining. Dysregulated gene and protein expression of the inflammatory and apoptotic genes could be modulated by stimulation and inhibition in the epithelial cells.

CONCLUSIONS

The local ME mucosal tissue is believed to modulate downstream immune activity after pathogen invasion via intrinsic cellular mechanism. Using translation approaches to target these molecular pathways may offer more reliable clinical resolution of otitis media in the future.

摘要

假设

中耳(ME)上皮组织发生改变是由于感染期间免疫调节发生变化。

引言

鼓室腔的上皮细胞在中耳炎的情况下代表了第一道防线。它们可以从典型的黏膜部位转化为呼吸上皮,反之亦然。我们的目标是在分子水平上描绘感染后上皮细胞的特定免疫反应。

方法

研究在健康和炎症性 ME 组织中进行,这些组织是在小鼠和人类模型的手术干预中以及人 ME 上皮细胞系的体外细胞模型中切除的。我们使用免疫组织化学法确定了 Toll 和 NOD 样免疫受体及其相关信号分子在蛋白质表达中的上皮定位。此外,我们还检查了由于直接刺激和抑制而导致的生长行为和基因表达。

结果

我们发现,根据其起源,炎症性 ME 上皮组织发生了临床和免疫生物学上可确认的转化,以及 Toll 样受体和核苷酸结合寡聚结构域样受体在细胞上皮衬里中的分布存在差异。上皮细胞中炎症和凋亡基因的失调基因和蛋白表达可以通过刺激和抑制来调节。

结论

局部 ME 黏膜组织被认为可以通过内在细胞机制在病原体入侵后调节下游免疫活性。使用翻译方法来靶向这些分子途径可能会为未来中耳炎的临床治疗提供更可靠的解决方案。

相似文献

1
Immunomodulatory Response of the Middle Ear Epithelial Cells in Otitis Media.
Otol Neurotol. 2024 Mar 1;45(3):e248-e255. doi: 10.1097/MAO.0000000000004096. Epub 2024 Jan 17.
2
Topical antibiotics with steroids for chronic suppurative otitis media.
Cochrane Database Syst Rev. 2025 Jun 9;6(6):CD013054. doi: 10.1002/14651858.CD013054.pub3.
3
Topical antibiotics for chronic suppurative otitis media.
Cochrane Database Syst Rev. 2025 Jun 9;6:CD013051. doi: 10.1002/14651858.CD013051.pub3.
4
Topical antiseptics for chronic suppurative otitis media.
Cochrane Database Syst Rev. 2025 Jun 9;6(6):CD013055. doi: 10.1002/14651858.CD013055.pub3.
5
Topical versus systemic antibiotics for chronic suppurative otitis media.
Cochrane Database Syst Rev. 2025 Jun 9;6(6):CD013053. doi: 10.1002/14651858.CD013053.pub3.
6
Antibiotics versus topical antiseptics for chronic suppurative otitis media.
Cochrane Database Syst Rev. 2025 Jun 9;6(6):CD013056. doi: 10.1002/14651858.CD013056.pub3.
7
Aural toilet (ear cleaning) for chronic suppurative otitis media.
Cochrane Database Syst Rev. 2025 Jun 9;6(6):CD013057. doi: 10.1002/14651858.CD013057.pub3.
9
Vaccines for preventing influenza in healthy children.
Cochrane Database Syst Rev. 2018 Feb 1;2(2):CD004879. doi: 10.1002/14651858.CD004879.pub5.
10
Interventions for acute otitis externa.
Cochrane Database Syst Rev. 2010 Jan 20(1):CD004740. doi: 10.1002/14651858.CD004740.pub2.

引用本文的文献

本文引用的文献

1
Resolution of otitis media in a humanized mouse model.
Front Genet. 2022 Nov 9;13:958540. doi: 10.3389/fgene.2022.958540. eCollection 2022.
2
Essential Role of the Innate Immune Adaptor RIP2 in the Response to Otitis Media.
Front Genet. 2022 Jul 12;13:893085. doi: 10.3389/fgene.2022.893085. eCollection 2022.
3
Immunomodulation as a Protective Strategy in Chronic Otitis Media.
Front Cell Infect Microbiol. 2022 Mar 30;12:826192. doi: 10.3389/fcimb.2022.826192. eCollection 2022.
5
NOD1/NOD2-mediated recognition of non-typeable activates innate immunity during otitis media.
Innate Immun. 2019 Nov;25(8):503-512. doi: 10.1177/1753425919872266. Epub 2019 Aug 31.
7
An in vitro model of murine middle ear epithelium.
Dis Model Mech. 2016 Nov 1;9(11):1405-1417. doi: 10.1242/dmm.026658. Epub 2016 Sep 22.
8
TLR2 promotes macrophage recruitment and Streptococcus pneumoniae clearance during mouse otitis media.
Pediatr Res. 2016 Dec;80(6):886-893. doi: 10.1038/pr.2016.154. Epub 2016 Jul 27.
9
Predominant Bacteria Detected from the Middle Ear Fluid of Children Experiencing Otitis Media: A Systematic Review.
PLoS One. 2016 Mar 8;11(3):e0150949. doi: 10.1371/journal.pone.0150949. eCollection 2016.
10
Innate Immunity: Orchestrating Inflammation and Resolution of Otitis Media.
Curr Allergy Asthma Rep. 2016 Jan;16(1):6. doi: 10.1007/s11882-015-0585-2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验